Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients
비인두 미생물총의 슈퍼 우세한 병원성 박테리아는 COVID-19 환자에서 2차 박테리아 감염을 유발합니다
Article
[키워드] 16S rRNA
16S rRNA gene
abundance
accounted
Acinetobacter
aggravate
analyzed
Bacterial
Bacterial infection
bacterial pneumonia
bacterial specy
cause
collected
Community
composed
coronavirus disease
Coronavirus disease 2019
Corynebacterium
Coverage
COVID-19
COVID-19 infection
COVID-19 patient
defined
difference
disease severity
Diversity
dominant
fatality
genus
High-throughput sequencing
Infection
Influenza
invasive
Lower respiratory tract
lower respiratory tract samples
microbiota
Mild
mild COVID-19 patients
mild infection
mild infections
nasopharyngeal
nasopharyngeal microbiota
nasopharynx
pathobiontic bacteria
pathogen
Patient
patients
patients with SARS-CoV-2
Pneumonia
previous study
respiratory infectious disease
respiratory tracts
responsible
rRNA
Sample
SARS-COV-2 infection
secondary
secondary bacterial infection
secondary bacterial pneumonia
Seven
severe COVID-19
Severe COVID-19 Infection
severe COVID-19 patients
severe group
severe pneumonia
significantly
significantly higher
Staphylococcus
upper
upper and lower respiratory tracts
upper respiratory tract
variety
was used
[DOI] 10.1128/spectrum.01956-21 PMC 바로가기 [Article Type] Article
[DOI] 10.1128/spectrum.01956-21 PMC 바로가기 [Article Type] Article